Breaking News

Pharmasol Adds Quality & Regulatory Professionals

August 15, 2014

Vassilopoulo and Chaturvedi to head QA and QC

Cheryl Vassilopoulos has been appointed vice president of Quality & Regulatory Affairs at Pharmasol Corp.  Ms. Vassilopoulos has more than 20 years of experience in pharmaceutical analytical method development, quality control, and quality assurance management. Prior to joining the company, she served as vice president of Quality & Regulatory Compliance at Precision Dermatology, Inc.  Previously, she held positions of increasing responsibility at Collegium Pharmaceutical, Inc. and Copley Pharmaceutical, Inc., where she managed teams of method development chemists and quality assurance associates for a broad range of dosage forms.

Also joining the company from Precision Dermatology are Lisa Pezzullo and Pam Lounsbury, serving as QA Compliance Manager and QA Development Manager, respectively.

Additionally, Dr. Surendra Chaturvedi has been appointed director of Quality Control at Pharmasol. Dr. Chaturvedi has more than 25 years of experience in the pharma and biotech industries in areas including multiple organic syntheses, analytical method development, quality control and process development. Dr. Chaturvedi has also managed a manufacturing and analytical contract lab, as well as managed large groups of both organic and analytical chemists in synthesizing and characterizing APIs. He has more than 15 publications in peer-reviewed journals and has presented at various conferences. 

Related Contract Manufacturing:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks